Polymorphisms in MMP 2 and TIMP 2 in Turkish patients with prostate cancer

Basit Öğe Kaydı
dc.authoridTR126568en_US
dc.authoridTR223147en_US
dc.authoridTR116588en_US
dc.authoridTR190473en_US
dc.authoridTR127797en_US
dc.authoridTR31156en_US
dc.contributor.authorYaykaşlı, Kürşat Oğuz
dc.contributor.authorKayıkçı, Muhammet Ali
dc.contributor.authorYılmaz, Nesibe
dc.contributor.authorSoğuktaş, Hatice
dc.contributor.authorDüzenli, Selma
dc.contributor.authorArslan, Ali Osman
dc.contributor.authorMetin, Ahmet
dc.contributor.authorKaya, Ertuğrul
dc.contributor.authorHatipoğlu, Ömer Faruk
dc.date.accessioned2017-04-14T06:09:26Z
dc.date.available2017-04-14T06:09:26Z
dc.date.issued2014
dc.departmentİnönü Üniversitesien_US
dc.description.abstractAim: Prostate cancer is the most commonly diagnosed malignancy and the second most common cause of cancer deaths in the Western male population. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs (TIMPs) modulate the remodeling of the extracellular matrix (ECM). The imbalance between MMPs and TIMPs may lead to an emergence of pathological processes such as cancer. In this study, the association between TIMP-2 (–418 G/C) and MMP-2 (–1306 C/T) polymorphisms and prostate cancer in the Turkish population was investigated. Materials and methods: Sixty-one prostate cancer patients and 46 healthy subjects were included in the study. DNA was isolated from 2 mL of peripheral blood taken from subjects, and genotypes were analyzed by the polymerase chain reaction-restriction fragment length polymorphism method. Results: The TIMP-2 –418 (GC) genotype was found in 15 cases (32.6%) in the control group and in 9 cases (14.8%) in the patients group, and statistical significance was determined (P = 0.037, OR = 0.346). The MMP-2 –1306 (CT) genotype was found 2.17 times more in the patient group than in the control group (P = 0.149, OR = 2.17). Conclusion: Our results show that the TIMP-2 –418 (GC) genotype had a putative protective effect against prostate cancer.en_US
dc.identifier.citationYaykaşlı, K. O. Kayıkçı, M. A. Yılmaz, N. Soğuktaş, H. Düzenli, S. Arslan, A. O. Metin, A. Kaya, E. Hatipoğlu, Ö. F. (2014). Polymorphisms in MMP 2 and TIMP 2 in Turkish patients with prostate cancer. TURKISH JOURNAL OF MEDICAL SCIENCES, 44, 839–843.en_US
dc.identifier.doi10.3906/sag-1305-63en_US
dc.identifier.endpage843en_US
dc.identifier.issn13000144
dc.identifier.issue44en_US
dc.identifier.startpage839en_US
dc.identifier.urihttp://online.journals.tubitak.gov.tr/openDoiPdf.htm?mKodu=sag-1305-63
dc.identifier.urihttps://hdl.handle.net/11616/6661
dc.language.isoenen_US
dc.publisherTURKISH JOURNAL OF MEDICAL SCIENCESen_US
dc.relation.ispartofTURKISH JOURNAL OF MEDICAL SCIENCESen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectMatrix metalloproteinasesen_US
dc.subjectProstate canceren_US
dc.subjectPolymorphismen_US
dc.subjectTissue inhibitors of metalloproteinasesen_US
dc.titlePolymorphisms in MMP 2 and TIMP 2 in Turkish patients with prostate canceren_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Makale Dosyası.pdf
Boyut:
95.9 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Makale Dosyası
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.71 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Sağlık Bilimleri Enstitüsü Diğer Yayınlar Koleksiyonu